Table I.
Association between clinicopathological features and miR-410 expression levels.
| miR-410 expression | ||||
|---|---|---|---|---|
| Factor | Cases (n) | High (6) | Low (34) | P-value |
| Age (years) | NS | |||
| ≥25 | 15 | 2 | 13 | |
| <25 | 25 | 4 | 21 | |
| Gender | NS | |||
| Male | 24 | 3 | 21 | |
| Female | 16 | 3 | 13 | |
| Tumor size (cm) | NS | |||
| ≥8 | 19 | 4 | 15 | |
| <8 | 21 | 2 | 19 | |
| Serum level of lactate dehydrogenase | NS | |||
| Elevated | 26 | 4 | 22 | |
| Normal | 14 | 2 | 12 | |
| Serum level of alkaline dehydrogenase | NS | |||
| Elevated | 28 | 5 | 23 | |
| Normal | 12 | 1 | 11 | |
| Clinical stage | NS | |||
| IIA | 23 | 3 | 20 | |
| IIB/III | 17 | 3 | 14 | |
| Response to chemotherapy | <0.05 | |||
| Good | 14 | 6 | 9 | |
| Poor | 26 | 0 | 26 | |
miR-410, microRNA-410; NS, not significant.